T 0395/18 (Oligosaccharides for preventing allergic reactions in infants) du 11.09.2020
- Identifiant européen de la jurisprudence
- ECLI:EP:BA:2020:T039518.20200911
- Date de la décision
- 11 septembre 2020
- Numéro de l'affaire
- T 0395/18
- Requête en révision de
- -
- Numéro de la demande
- 12703533.5
- Classe de la CIB
- A23C 9/20
- Langue de la procédure
- Anglais
- Distribution
- Non distribuées (D)
- Téléchargement
- Décision en anglais
- Versions JO
- Aucun lien JO trouvé
- Autres décisions pour cet affaire
- -
- Résumés pour cette décision
- -
- Titre de la demande
- MATERNAL SUPPLEMENT TO ENHANCE IMMUNE SYSTEM OF AN INFANT
- Nom du demandeur
- N.V. Nutricia
- Nom de l'opposant
- Société des Produits Nestlé S.A.
- Chambre
- 3.3.09
- Sommaire
- -
- Dispositions juridiques pertinentes
- European Patent Convention Art 111(1) (2007)European Patent Convention Art 123(2) (2007)European Patent Convention Art 54(5) (2007)European Patent Convention Art 83 (2007)European Patent Convention R 106 (2007)Rules of procedure of the Boards of Appeal Art 11 (2020)Rules of procedure of the Boards of Appeal Art 12(2) (2020)Rules of procedure of the Boards of Appeal Art 13(1) (2020)Rules of procedure of the Boards of Appeal Art 13(2) (2020)Rules of procedure of the Boards of Appeal Art 25(3) (2020)
- Mots-clés
- Main request: sufficiency of disclosure - (no)
Auxiliary requests 1 to 6: sufficiency of disclosure - (no)
Auxiliary request 7: added matter - (no); sufficiency of disclosure - (yes)
Admissibility of late filed submissions - (yes)
Violation of the right to be heard - (no)
Serious doubts that a therapeutic effect is achieved - (yes)
Oral proceedings by videoconference - Exergue
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division for further prosecution.